F2 and liver cancer: There were significant differences between the two groups in sex, history of liver cancer treatment, HCV‐RNA levels, serum albumin levels, AST levels, γ‐GTP levels, creatinine, eGFR, prothrombin activity, platelet counts, and AFP levels.